Sleeping Bruxism Treatment Market

Sleep bruxism, which leads to grinding teeth at night, is a condition that can result in disturbed sleep, is an increasingly common condition. Reports that assess the healthcare industry have been presented by Market Research Future, which creates reports on numerous industry verticals that examine the market progress and forecasts. Sleeping Bruxism Treatment Market Size is projected to be worth USD 1.03 Billion by 2032, registering a CAGR of 6% during the forecast period.

The rising pediatric population and altering lifestyles are expected to motivate the sleeping bruxism treatment market globally. The increased accessibility to therapeutic medicines is projected to create an increased impetus for growth in the coming years. The enhanced quality in preventive measures for treating sleeping bruxism is expected to enhance the potential for growth in the approaching period.

Major Key Players:

The Key Market Players are Pfizer Inc. (U.S.), Ipsen Biopharmaceuticals, Inc. (U.S.), Henry Schein, Inc. (U.S.), Carestream Dental (U.S.), PLANMECA OY (Finland), Akervall Technologies Inc. (U.S.), Merz Pharma GmbH & Co. KGaA (Germany), Randmark Dental Products, LLC (U.S.), S4S Dental Laboratory (U.K.), Patterson Dental Supply, Inc. (U.S.), Ivoclar Vivadent AG (Liechtenstein), and others.

Sleeping Bruxism Treatment Market Insights and Analysis by Type (Primary Bruxism, Secondary Bruxism), by Treatment (Dental Approaches, Medication), by Cause (Obstructive Sleep Apnea, Gastroesophageal Reflux Disease (GERD), Malocclusion, Sleep Paralysis), by Patient Type (Pediatric, Adult), by End User (Hospitals & Clinics, Dental Clinics) and Region (Americas, Europe, Asia-Pacific, and Middle East & Africa) - Forecast till 2032.

Segment Analysis

MRFR’s market study with regard to sleeping bruxism treatment covers segments like type, diagnosis, treatment type, cause, patient type, and end-user.

The main types considered in the market report include primary as well as secondary. The largest market in 2017 belonged to secondary bruxism, as a result of the surge in sleep disorders, rising intake of medicines that cause dental issues and evolving lifestyles in light of growing stress.

Treatment-wise, the key market categories can be dental approaches as well as medication. The dental approaches-based segments in the market are NTI-tss device and mouth guard. The medication-wise categories include Botox injections, anti-anxiety drugs and muscle relaxants.

The key causes of sleeping bruxism identified in the market study include sleep paralysis, obstructive sleep apnea, malocclusion, gastroesophageal reflux disease (GERD), and more. Between these, the obstructive sleep apnea category can touch USD 233.20 million by 2023, and also achieve an expansion rate of 7.0% during the given period.

Pediatric and adult remain the two patient type segments in the market. In the year 2017, the pediatric segment took the lead, as hyperactivity has become quite prevalent among children, in addition to anger issues, rising pain from teething and earache, and stress.

Some of the prominent end-users in the worldwide industry are dental clinics, hospitals, and others.

Regional Analysis

The Americas, the Middle East and Africa/MEA, Asia Pacific/APAC and Europe are the top markets for sleeping bruxism treatment.

The Americas, in 2017, measured up to a share of 39.1% in the sleeping bruxism treatment market. The key growth promoters include the escalating anxiety and stress among people and the significant surge in government spending on the target field. Mounting healthcare insurance among people also contributes to the expansion of the regional market. A few other factors encouraging market growth can be the rising introduction of innovative and advanced devices, and the burgeoning geriatric population in the region, especially in the United States, Mexico and Canada. 

Europe has procured the second position in the global market, due to the apparent surge in sleeping bruxism cases among children and adults alike. Strong economy, expanding dental awareness and high number of dental clinics aid significantly in the market growth in Europe. An expanding pool of patients suffering from snoring, irregular breathing and sleep disorders has also given a boost to sleeping bruxism, marking substantial market progress in the region.

With a steady advancement rate, the APAC market is largely backed by the rapid increase in the use of quality healthcare technology, fast economic growth and the massive population. Increasing spending on healthcare and the considerable expansion of the pediatric population also serves as catalysts in the market growth here. The growing knowledge level among people about sleep bruxism and the thriving dental industry in India, Japan, South Korea and China also bolster the market demand in APAC.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com